OrthoSystems, Inc. is a privately held, start-up biotechnology company headquartered in Syracuse, New York. The company's mission is to develop its novel switch technology capable of a) creating rapid diagnostic tools for detection of chemical and biological targets, and b) leveraging this diagnostic platform for drug discovery applications. OrthoSwitch™, OrthoSystems' platform technology, has demonstrated the ability of transducing molecular recognition of biological targets into a real-time (seconds) optical signal for identifying environmental and terrorist released contaminants in liquid systems. OrthoSwitch solutions are built on patent-pending biotechnology based on years of leading-edge biological research and industry partnerships at Syracuse University. copyright © 2004 OrthoSystems, Inc.